 "An extra dose of tax on medicines")
The National Pharmaceutical Pricing Authority (NPPA) has turned down the industry's demand to allow a one-time price revision of non-scheduled drugs following GST implementation.
NPPA caps the prices of drugs under the National List of Essential Medicines (NLEM). In respect of other drugs the government rules restrict companies from hiking price over 10 per cent in twelve months.
The Indian Drug Manufacturers Association had demanded a one-time waiver from the rule thus enabling companies to hike prices of products which have already been revised upwards by 10 per cent.
“The companies will have no option but to
NPPA caps the prices of drugs under the National List of Essential Medicines (NLEM). In respect of other drugs the government rules restrict companies from hiking price over 10 per cent in twelve months.
The Indian Drug Manufacturers Association had demanded a one-time waiver from the rule thus enabling companies to hike prices of products which have already been revised upwards by 10 per cent.
“The companies will have no option but to
